Results 181 to 190 of about 29,738 (225)

Cutaneous leishmaniasis in Yemen

International Journal of Dermatology, 1999
AbstractBackground Cutaneous leishmaniasis is widespread in the Yemen, but has not been fully documented.Methods We have studied 42 cases from the Hajjah and Amran Governorates of the Yemen Republic. The clinical profile of these cases was recorded in a special protocol.
M L, Khatri, N, Haider
openaire   +2 more sources

Disseminated Cutaneous Leishmaniasis

International Journal of Dermatology, 1989
Observation chez un patient presentant une plaque ulceree d'apparition progressive depuis 9 mois. Le patient avait sejourne en Irak pendant 3 ans et etait revenu en Inde 3 mois avant le developpement de la lesion. L'examen revele plusieurs autres plaques et un rash erythemateux dans le dos et sur les membres inferieurs.
V K, Sharma, S, Kaur, R C, Mahajan, K, Joshi, B, Kumar   +4 more
openaire   +2 more sources

Miltefosine and cutaneous leishmaniasis

Current Opinion in Infectious Diseases, 2012
Miltefosine is a new oral treatment against leishmaniasis. The evidence about its use in New and Old World cutaneous leishmaniasis is presented and discussed.Miltefosine is being tested with small clinical trials mainly in endemic cutaneous leishmaniasis regions of South America and Iran.
Paulo R L, Machado, Gerson, Penna
openaire   +2 more sources

Cryosurgery in cutaneous leishmaniasis

British Journal of Dermatology, 1982
Thirty patients with cutaneous leishmaniasis were treated with cryotherapy using a CO2 cryomachine and all were cured without noticeable scarring within 4-5 weeks, with no relapse. Histopathological examination showed that cryotherapy eradicated all parasites in less than 1 hour. Leishmania tropica, L. ethiopica and L.
A, Bassiouny, M, El Meshad, M, Talaat, K, Kutty, B, Metawaa   +4 more
openaire   +2 more sources

Diagnosis of cutaneous leishmaniasis

Current Opinion in Infectious Diseases, 2003
The purpose of this review is to discuss some of the most important issues in the clinical and laboratory diagnosis of cutaneous leishmaniasis. The former is based on clinical experience and the latter on the literature published within the last couple of years.
openaire   +2 more sources

Recurrent cutaneous leishmaniasis

Journal of the American Academy of Dermatology, 1983
A patient is presented who has a 71-year history of recurrent cutaneous leishmaniasis, despite treatment with antimonials, antituberculous drugs, and surgery. Classification and treatment of cutaneous leishmaniasis are discussed.
R A, Strick, M, Borok, H C, Gasiorowski
openaire   +2 more sources

Cutaneous and Mucocutaneous Leishmaniasis

Infectious Disease Clinics of North America, 2012
Tegumentary leishmaniases are caused by approximately 15 species of protozoa of the genus Leishmania. They prevail in tropical and subtropical areas of the Old and New World but human mobility also makes them a medical problem in nonendemic areas. Clinical manifestations may comprise cutaneous and mucocutaneous forms that may be localized, disseminated,
Hiro, Goto, José Angelo, Lauletta Lindoso   +1 more
openaire   +2 more sources

Cutaneous leishmaniasis treatment

Travel Medicine and Infectious Disease, 2007
The causative species of cutaneous leishmaniasis determines the clinical features and courses, and treatments. Intralesional or systemic antimonials are the gold standard for the treatment of these diseases. However, as for visceral leishmaniasis, other therapeutic options appear promising.
Philippe, Minodier, Philippe, Parola
openaire   +2 more sources

Immunofluorescence in Cutaneous Leishmaniasis

Dermatologica, 2009
A case of acute cutaneous leishmaniasis is reported in which skin biopsy of the lesion revealed deposits of IgM, fibrinogen and C3 in the blood vessel wall and granular deposits of IgG and C3 at the dermoepidermal junction. No immune complexes were detected in the healthy unaffected skin in the same patient and no circulating immune complexes were ...
S, Brenner, A, Srebrnik, B, Hazaz, A, Krakowski   +3 more
openaire   +2 more sources

Treatment of cutaneous leishmaniasis

Journal of the American Academy of Dermatology, 1994
The World Health Organization estimates that approximately 400,000 new cases of leishmaniasis occur worldwide each year. Cutaneous leishmaniasis is being encountered more frequently in the United States because of increasing travel and immigration from endemic areas.
A B, Koff, T, Rosen
openaire   +2 more sources